Structural and Functional Characterisation of a Specific Antidote for Ticagrelor.
Buchanan, A., Newton, P., Pehrsson, S., Inghardt, T., Antonsson, T., Svensson, P., Sjogren, T., Oster, L., Janefeldt, A., Sandinge, A., Keyes, F., Austin, M., Spooner, J., Gennemark, P., Penney, M., Howells, G., Vaughan, T., Nylander, S.(2015) Blood 125: 3484
- PubMed: 25788700 
- DOI: 10.1182/blood-2015-01-622928
- Primary Citation of Related Structures:  
- PubMed Abstract: 
Ticagrelor is a direct-acting reversibly binding P2Y12 antagonist and is widely used as an antiplatelet therapy for the prevention of cardiovascular events in acute coronary syndrome patients. However, antiplatelet therapy can be associated with an i ...